FBI Investigates Omaha Pharmaceutical Company
April 4th, 2013 // 2:26 pm @ jmpickett
Channel 6 in Omaha, NE is working to find out what the FBI was doing at an Omaha pharmaceutical company Wednesday afternoon.
Workers nearby said they saw FBI agents at Pharmaceutical Technologies
, Inc. near 136th and California.
The Omaha bureau said local agents are assisting another agency with the investigation. They referred us to the U.S. Attorney’s Office in Texas to get more information.
Avoid the CDRH eCopy Chaos – How to Prepare a Compliant eCopy Submission
A spokeswoman there said she couldn’t comment on the investigation.
PTI has released a statement about the investigation:
“Pharmaceutical Technologies, Inc. was visited by federal authorities at its Omaha headquarters Wednesday morning, April 3, 2013. PTI learned recently that the Texas U.S. Attorney’s Office is leading an inquiry into certain business practices and since that time, PTI has cooperated fully with the government during this routine inquiry. The quality of care or issues that could affect patient safety are not involved. The company is confident this will be resolved. PTI will continue to operate in both the spirit and letter of all regulations and laws.”
Upcoming Expertbriefings.com Webinars 2013
Check out our latest FDA drug and device news, too
- April 10 – Avoid the CDRH eCopy Chaos – How to Prepare a Compliant eCopy Submission
- April 11 – The Quality Manager Gets Fired, the $100,000 Compliance SNAFU, And 21 Tips and Tricks For Your Next Audit
- April 18 – Why You May Want to Move Your Pharma Company to Kansas – 483 and Warning Letter Trends
- April 21 – $500K on Compliance or $300 Million for Consent Decree? – Essential FDA Compliance Tips for Sr Management
- April 29 – Audit Your Lab Like an Expert FDA Auditor: A Roadmap to Lab Compliance
- April 30 – FDA Hands Out CAPA 483s Like Candy – Avoid Them With a Closed Loop CAPA SystemÂ
- May 1 – Avoiding Warning Letter Disasters With a Strong Contractor Quality Agreement
- May 7 – FDA Recall Chief Update – How to Design a Bulletproof Product Recall Strategy
